華康生物醫學：須予披露交易及給予實體貸款 有關收購目標公司19%股權及提供貸款的還款安排

Hong Kong Stock ExchangeMay 14 06:52 ET · Announcements

華康生物醫學：2023年報

Hong Kong Stock ExchangeApr 29 07:36 ET · Announcements

Huakang Biomedical (08622) completed placement of 31 million shares to raise approximately HK$2.96 million

Huakang Biomedical (08622) issued an announcement. The conditions for the placement have been met, and on April 2, 2024...

Zhitong FinanceApr 23 07:27 ET

Huakang Biomedical (08622.HK): Chen Jiansheng Resigns as Independent Non-Executive Director

Huakang Biomedical (08622.HK) announced that Chen Jiansheng resigned as an independent non-executive director of the company, a member of the Audit Committee and Nomination Committee in order to invest more time in his personal business and other matters, effective April 2, 2024.

Gelonghui FinanceApr 2 05:01 ET

華康生物醫學：截至二零二三年十二月三十一日止年度的年度業績公告

Hong Kong Stock ExchangeMar 28 08:53 ET · Announcements

Huakang Biomedical (08622) Fa Ying Guang expects annual shareholders' losses to be no more than 5.8 million yuan

Huakang Biomedical (08622) issued an announcement that it is expected that the company owner's losses during the period will end in December 2023...

Zhitong FinanceMar 25 07:35 ET